Benolea EFLA 943 olive leaf extract was shown to be as effective as the hypertension drug Captopril in lowering blood pressure.
Frutarom’s (Wadenswil, Switzerland) Benolea EFLA 943 olive leaf extract was shown to be as effective as the hypertension drug Captopril in lowering blood pressure, according to recent study results the company presented at the Vitafoods trade show in May.
Conducted at the University of Indonesia, the randomized, double-blind, double-dummy, active controlled study involved 232 participants ages 25 to 60 years with stage-1 hypertension. During the treatment period, subjects were either given one 500-mg Benolea supplement or one 12.5-mg Captopril tablet, both taken twice a day.
According to Frutarom, the researchers found that both Benolea and Captopril effectively lowered systolic and diastolic blood pressure in a comparable manner, compared to baseline.
Moreover, Benolea was found to significantly reduce total cholesterol and plasma triglyceride levels, while the conventional drug did not. “Particularly in participants with high baseline triglyceride levels (>200 mg/dl), the reduction was remarkable: the triglycerides diminished by 53.13 mg/dl. Such positive effects were not observed in the Captopril group,” Frutarom stated.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
SourceOne Global Partners to distribute Qualitas Health’s microalgae omega-3 ingredient globally
August 15th 2024SourceOne Global Partners has announced a partnership with Qualitas Health Inc., (dba iwi life) to introduce the company’s trademarked AlmegaPL microalgae omega-3 ingredient to the global marketplace.